Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small molecular microbial products enhancing immune response.

H Umezawa

    Antibiotics and Chemotherapy
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Synthesis and antitumor activity of 4'-O-acylanthracyclines.

    The Journal of antibiotics·1992
    Same author

    Ascorbic acid and adriamycin toxicity.

    The American journal of clinical nutrition·1991
    Same author

    Synthesis of 3'-deoxy-3'-fluorokanamycin A and 3',4'-dideoxy-3'-fluorokanamycin A.

    Carbohydrate research·1991
    Same author

    High-performance liquid chromatographic determination of deoxyspergualin in dog plasma with ultraviolet detection.

    Journal of chromatography·1990
    Same author

    Post-ischaemic treatment with the prostacycline analogue TTC-909 reduces ischaemic brain injury.

    Acta neurochirurgica. Supplementum·1990
    Same author

    Local cerebral blood flow and glucose metabolism in hydrostatic brain oedema.

    Acta neurochirurgica. Supplementum·1990

    Bestatin, an inhibitor of aminopeptidases, enhances immune response and demonstrates therapeutic effects against experimental tumors. This compound shows low toxicity and synergistic action with antitumor agents, offering potential in cancer treatment.

    Area of Science:

    • Microbiology and Immunology
    • Pharmacology
    • Biochemistry

    Background:

    • Microbial secondary metabolites, often plasmid-biosynthesized, possess diverse pharmacological activities beyond antimicrobial properties.
    • Cell surface enzymes like aminopeptidases, alkaline phosphatase, and esterase play roles in modulating immune responses.
    • Inhibitors of these enzymes can significantly influence immune system function with minimal toxicity.

    Purpose of the Study:

    • To investigate the pharmacological activities of microbial products, specifically enzyme inhibitors.
    • To evaluate the immunomodulatory effects and therapeutic potential of bestatin, an aminopeptidase inhibitor.

    Main Methods:

    • Administration of bestatin at low doses (0.1-100 µg/mouse) to assess its impact on immune response.

    Related Experiment Videos

  • Evaluation of bestatin's effect on delayed-type hypersensitivity and immune resistance to tumor cell inoculation.
  • Assessment of bestatin's synergistic effects with conventional antitumor agents in experimental tumor models.
  • Analysis of bestatin's therapeutic efficacy as a standalone treatment for solid tumors.

    • Main Results:

    • Bestatin significantly enhanced delayed-type hypersensitivity across a broad dosage range.
    • Bestatin conferred immune resistance against subsequent tumor cell challenges.
    • Synergistic therapeutic effects were observed when bestatin was combined with other antitumor agents.
    • Bestatin monotherapy demonstrated potent therapeutic activity against slow-growing solid tumors.

    Conclusions:

    • Bestatin exhibits potent immunomodulatory properties, enhancing cellular immunity.
    • Bestatin possesses direct antitumor activity and acts synergistically with existing cancer therapies.
    • The low toxicity profile and dual action make bestatin a promising candidate for cancer treatment strategies.